apomorphine has been researched along with Neuroblastoma in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Hur, J; Kim, J; Kim, MC; Lee, CH; Li, H; Tran, HNK; Yang, HO | 1 |
| Brekk, OR; Kirik, D; Landeck, N; Papadopoulou-Daifoti, Z; Papasilekas, T; Pitychoutis, PM; Stefanis, L; Xilouri, M | 1 |
| Galeotti, N; Ghelardini, C; Peroni, D; Quattrone, A; Sanna, MD | 1 |
| Duan, SS; Ha, S; Li, ZA; Shi, YL; Wang, XL; Zhang, XS | 1 |
| Alvira-Botero, X; España-Serrano, L; Hoenicka, J; Jiménez-Arriero, MA; Kremer, L; Palomo, T; Pérez-González, R; Ponce, G; Quiñones-Lombraña, A; Rodríguez-Jiménez, R | 1 |
| Himeno, E; Iinuma, KM; Kira, J; Ma, L; Miyoshi, K; Nakamura, N; Ohyagi, Y; Sakae, N; Soejima, N; Yamasaki, R; Yanagihara, YT | 1 |
| Chan, YS; Chen, LW; Chu, JM; Yung, KK | 1 |
| Mandel, S; Weinreb, O; Youdim, MB | 1 |
| Kääriäinen, T; Kulkarni, SK; Manáková, S; Männistö, PT; Singh, A; Taari, H | 1 |
| Adachi, T; Hara, H; Ohta, M | 1 |
| Kääriäinen, TM; Kekki, H; Lecklin, A; Lehtonen, S; Männistö, PT; Nenonen, T; Ossola, B; Piltonen, M; Raasmaja, A | 1 |
| Bräutigam, M; Dreesen, R; Herken, H | 1 |
| Bräutigam, M; Kittner, B; Laschinski, G | 1 |
| Berry-Kravis, E; Dawson, G; Freedman, SB | 1 |
| Martres, MP; Riou, JF; Schwartz, JC; Sokoloff, P | 1 |
| Dwork, A; Fahn, S; Flaster, E; Garcia de Yebenes, J; Herbert, J; Latov, N; Mena, MA; Slonim, D | 1 |
| Bräutigam, M; Herken, H; Kittner, B; Laschinski, G | 1 |
| Gilmer, KN; Prasad, KN | 1 |
18 other study(ies) available for apomorphine and Neuroblastoma
| Article | Year |
|---|---|
Extract of Polygala tenuifolia, Angelica tenuissima, and Dimocarpus longan Reduces Behavioral Defect and Enhances Autophagy in Experimental Models of Parkinson's Disease.
Topics: Angelica; Animals; Apomorphine; Autophagy; Cell Line, Tumor; Corpus Striatum; Dopaminergic Neurons; Drug Evaluation, Preclinical; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phytotherapy; Plant Extracts; Polygala; Random Allocation; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Sapindaceae; Saponins; Substantia Nigra; Triterpenes; Tyrosine 3-Monooxygenase | 2021 |
Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration.
Topics: alpha-Synuclein; Amphetamine; Analysis of Variance; Animals; Apomorphine; Autophagy; Cells, Cultured; Cerebral Cortex; Corpus Striatum; Dependovirus; Dopamine; Embryo, Mammalian; Enzyme Inhibitors; Female; Gene Expression Regulation; Genetic Vectors; Green Fluorescent Proteins; Hemagglutinins; Humans; Lysosomal Membrane Proteins; Lysosomal-Associated Membrane Protein 2; Macrolides; Mice; Molecular Chaperones; Motor Activity; Nerve Degeneration; Neuroblastoma; Neurons; Rats; Transfection; Tyrosine 3-Monooxygenase | 2013 |
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.
Topics: Analgesics, Non-Narcotic; Animals; Anti-HIV Agents; Apomorphine; Calcium Channel Blockers; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; ELAV Proteins; ELAV-Like Protein 4; Exploratory Behavior; Gene Expression Regulation; Hyperalgesia; Male; Mice; Motor Activity; Neuroblastoma; Pain; Pain Threshold; Peripheral Nervous System Diseases; Ryanodine Receptor Calcium Release Channel; Spinal Cord; Zalcitabine | 2015 |
Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
Topics: Abietanes; Animals; Apomorphine; Apoptosis; Cell Survival; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Gene Expression Regulation; Glutathione; Humans; Male; Mice; Mice, Inbred C57BL; Neuroblastoma; Neuroprotective Agents; Neurotoxicity Syndromes; NF-E2-Related Factor 2; Oxidopamine; Reactive Oxygen Species; Signal Transduction; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase | 2015 |
The ANKK1 gene associated with addictions is expressed in astroglial cells and upregulated by apomorphine.
Topics: Animals; Apomorphine; Astrocytes; Cells, Cultured; Central Nervous System; Dopamine Agonists; Embryo, Mammalian; Glioma; Humans; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Neuroblastoma; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Receptors, Dopamine D2; Sequence Alignment; Sequence Analysis, Protein; Substance-Related Disorders; Sulpiride; Tretinoin; Up-Regulation | 2010 |
Activation of glutathione peroxidase and inhibition of p53-related apoptosis by apomorphine.
Topics: Apomorphine; Apoptosis; Catalase; Cell Line, Tumor; Cell Survival; Death Domain Receptor Signaling Adaptor Proteins; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Glutathione; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Glutathione Reductase; Humans; Hydrogen Peroxide; Neuroblastoma; Oxidative Stress; Teprotide | 2011 |
Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
Topics: Analysis of Variance; Animals; Apomorphine; bcl-Associated Death Protein; Caspase 3; Cell Death; Cell Line, Tumor; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; L-Lactate Dehydrogenase; Male; Motor Activity; Neuroblastoma; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Peptide Fragments; Proto-Oncogene Proteins c-akt; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Rotarod Performance Test; Signal Transduction; Substance P; Sympatholytics; Time Factors; Tyrosine 3-Monooxygenase | 2011 |
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells.
Topics: Antioxidants; Apomorphine; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Catechin; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation; Humans; Melatonin; Neuroblastoma; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2003 |
Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells.
Topics: Animals; Apomorphine; Behavior, Animal; Caspase 3; Caspases; Cell Death; Cell Line, Tumor; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Immunophilins; Male; Motor Activity; Nerve Degeneration; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Random Allocation; Rats; Rats, Wistar; Tacrolimus | 2005 |
Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway.
Topics: Adrenergic Agents; Apomorphine; Benzazepines; Cell Death; Cell Line, Tumor; Cell Survival; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Flow Cytometry; Heme Oxygenase-1; Humans; Neuroblastoma; NF-E2-Related Factor 2; Oxidopamine; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction | 2006 |
Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
Topics: Amphetamine; Animals; Antioxidants; Apomorphine; Behavior, Animal; Cell Line, Tumor; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Male; Motor Activity; Neuroblastoma; Oxidopamine; Parkinson Disease; Quercetin; Rats; Rats, Wistar; Substantia Nigra; Tetrazolium Salts; Thiazoles; Tyrosine 3-Monooxygenase | 2008 |
Dopa-release from mouse neuroblastoma clone N 1 E-115 into the culture medium. A test for tyrosine hydroxylase activity.
Topics: Animals; Apomorphine; Catecholamines; Cells, Cultured; Clone Cells; Culture Media; Dihydroxyphenylalanine; Mice; Neuroblastoma; Proteins; Tyrosine; Tyrosine 3-Monooxygenase | 1982 |
Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.
Topics: Animals; Apomorphine; Biopterins; Cells, Cultured; Corpus Striatum; Dihydroxyphenylalanine; In Vitro Techniques; Kinetics; Male; Neuroblastoma; Pheochromocytoma; Rats; Rats, Inbred Strains; Tyrosine 3-Monooxygenase | 1984 |
Specific receptor-mediated inhibition of cyclic AMP synthesis by dopamine in a neuroblastoma X brain hybrid cell line NCB-20.
Topics: Alprostadil; Animals; Apomorphine; Brain; Cell Line; Cell Membrane; Clonidine; Cricetinae; Cricetulus; Cyclic AMP; Dopamine; Hybrid Cells; Mice; Neuroblastoma; Prostaglandins E; Receptors, Dopamine; Serotonin; Spiperone | 1984 |
Presence of dopamine D-2 receptors in human tumoral cell lines.
Topics: Apomorphine; Breast Neoplasms; Cell Membrane; Digestive System Neoplasms; Dopamine; Humans; Iodine Radioisotopes; Leukemia; Lung Neoplasms; Neoplasms; Neuroblastoma; Phenethylamines; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride; Tumor Cells, Cultured | 1989 |
Biochemical properties of monoamine-rich human neuroblastoma cells.
Topics: Animals; Apomorphine; Behavior, Animal; Cell Line; Dopamine; HLA Antigens; Humans; Hydroxydopamines; Male; Neuroblastoma; Norepinephrine; Oxidopamine; Rats; Substantia Nigra; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 1989 |
Effect of apomorphine, alpha-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cell lines (PC-12 and N1E-115).
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Animals; Apomorphine; Cell Line; Dihydroxyphenylalanine; Dopamine; Haloperidol; Methyltyrosines; Neuroblastoma; Pheochromocytoma; Rats; Reserpine | 1985 |
Demonstration of dopamine-sensitive adenylate cyclase in malignant neuroblastoma cells and change in sensitivity of adenylate cyclase to catecholamines in "differentiated" cells.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Catecholamines; Cell Line; Cyclic AMP; Dopamine; Haloperidol; Mice; Neuroblastoma; Norepinephrine; Phentolamine; Propranolol; Prostaglandins; Stimulation, Chemical | 1974 |